About this trial
Although studies exist demonstrating the effects of single-session action observation training on bradykinesia in patients with Parkinson's disease, research investigating the long-term application of such training remains limited. Furthermore, the broader literature indicates that action observation training has typically been conducted in simulated environments or by using recordings obtained from healthy individuals. The aim of the present study is to examine the effects of action observation training, delivered in a fully immersive virtual reality environment using each patient's own 3D motion recordings, on bradykinesia and other disease-related parameters.
Eligibility criteria
Qualifiers
Voluntary agreement to participate in the study
Clinical diagnosis of Parkinson's disease confirmed by a neurologist
Ongoing treatment with antiparkinsonian medication
Hoehn and Yahr (H-Y) stage ≤ 3
Disqualifiers
Presence of additional neurological disorders other than Parkinson's disease
Change in medication dosage within the past month
Score of ≥ 10 on the Simulator Sickness Questionnaire
Presence of amblyopia, strabismus, or pathologies impairing focus, depth perception, or normal 3D vision
Trial design
Treatments tested in this trial
- Patient-Specific VR Action Observation Training
- Healthy-Model VR Action Observation Training